Table 1.

Clinical parameters for the 98 lung adenocarcinoma (LUAD) from The Cancer Genome Atlas (TCGA) samples categorized based on the clinical outcome of tumor progression.

Parameters	Disease-Free	Recurred/Progressed
Patients	44	54
N0	27	31
N1	11	16
N2	5	7
NX	1	0
Stage IA	12	9
Stage IB	14	17
Stage IIA	3	6
Stage IIB	10	14
Stage IIIA	5	8
Median Age (years)	67.0	67.0
Age Range (years)	41–83	42–84
Male	18	25
Female	26	29
Neoadjuvant Treatment	0	0
Smoking History	37	47
Lifelong Non-Smoker	6	7